BRIEF-3D signatures plans to announce clinical trial for Hodgkin's Lymphoma precision medicine test in coming months
Oct 17 (Reuters) - 3d Signatures Inc :
* 3DS plans to announce a clinical trial for a Hodgkin's Lymphoma precision medicine test in coming months
* Expects to engage laboratory partner in validation, approval of a Hodgkin's Lymphoma Laboratory Developed Test (LDT) for Canada in 2017 Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.